circulating tumor DNA (ctDNA): Clinical Trials

2 trials of circulating tumor DNA (ctDNA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow circulating tumor DNA (ctDNA): new trials by email Literature Review of circulating tumor DNA (ctDNA) trials Research Report on circulating tumor DNA (ctDNA)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
circulating tumor DNA (ctDNA) - Metastatic Invasive Lobular Carcinoma (mILC)
RecruitingJulia Foldi202024-12-122026-01-20
Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC
WGS and RNA sequencing, circulating tumor DNA (ctDNA), FDG PET/CT imaging - High Grade Ovarian Serous Adenocarcinoma, High Grade Serous Carcinoma
Not applicableRecruitingTurku University Hospital2002012-02-012025-01-16

Conditions studied

Carcinoma, Lobular (1)  ·  Ovarian Neoplasms (1)

Sponsors

Julia Foldi (1)  ·  Turku University Hospital (1)

Countries

Finland (1)  ·  United States (1)

Top investigators

Johanna Hynninen, MD, PhD (1)  ·  Julia Foldi, MD, PhD (1)  ·  Sampsa Hautaniemi, DTech, Prof (1)

Results publications

PMID 37207655, PMID 40885189